e-learning
resources
Virtual 2021
07.09.2021
COPD pharmacology: from basic science to real-world data
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD exacerbation and use of methotrexate – a nationwide study of 58,580 outpatients
C. Bergsøe (Hellerup, Denmark), P. Sivapalan (Roskilde, Denmark), J. Eklöf (Hellerup, Denmark), Z. Saghir (Hellerup, Denmark), R. Sørensen (Hellerup, Denmark), M. Saeed (Hellerup, Denmark), J. Jensen (Copenhagen, Denmark)
Source:
Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Session:
COPD pharmacology: from basic science to real-world data
Session type:
Oral Presentation
Number:
2950
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Bergsøe (Hellerup, Denmark), P. Sivapalan (Roskilde, Denmark), J. Eklöf (Hellerup, Denmark), Z. Saghir (Hellerup, Denmark), R. Sørensen (Hellerup, Denmark), M. Saeed (Hellerup, Denmark), J. Jensen (Copenhagen, Denmark). COPD exacerbation and use of methotrexate – a nationwide study of 58,580 outpatients. 2950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
A retrospective study of antibiotic prescribing for patients admitted to hospital with exacerbation of COPD
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020
Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Acute exacerbation of COPD patients therapy priorities: A survey study
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study
Source: Annual Congress 2010 - Management of airway disease
Year: 2010
Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009
Characteristics of asthma patients with frequent exacerbations – an observational study in Sweden
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017
A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study
Source: Eur Respir J, 55 (2) 1901335; 10.1183/13993003.01335-2019
Year: 2020
Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005
Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study
Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019
Year: 2019
Procalcitonin-guided assessment of bacterial etiological role in patients admitted for severe COPD exacerbations: a double-blind study
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study
Source: Eur Respir J 2006; 28: Suppl. 50, 313s
Year: 2006
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
Influence of previous admissions on audit outcomes in patients admitted with acute exacerbation of COPD (AECOPD)
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept